CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been modified to resist enzymatic degradation and conjugated with a maleimidopropionic acid (MPA) group that binds to serum albumin. This conjugation extends the peptide's half-life from minutes to approximately 6-8 days, enabling sustained elevation of growth hormone and IGF-1 levels. CJC-1295 with DAC is commonly used in combination with Ipamorelin for synergistic GH release. Available in pharmaceutical-grade bulk supply with comprehensive analytical documentation.
| Molecular Weight | 3647.28 g/mol |
| Purity | ≥98% (HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| CAS | 863288-34-0 |
| Half-life | ~6-8 days |
Long-acting growth hormone releasing hormone (GHRH) analog with Drug Affinity Complex for sustained GH elevation over 7-10 days.
We supply CJC-1295 with DAC at ≥98% (HPLC) purity. Higher purity grades are available for pharmaceutical applications upon request.
Minimum order quantities for wholesale CJC-1295 with DAC depend on the quantity and purity grade required. Contact our sales team for specific pricing and MOQ information.
CJC-1295 with DAC should be stored at -20°C, protected from light in a desiccated environment. Proper cold-chain shipping is maintained for all deliveries.
Body Protection Compound-157 — a pentadecapeptide for systemic and localized tissue healing of the g...
View Details Pharmaceutical PeptidesHighly selective growth hormone releasing peptide (GHRP) with minimal side effects — the gold standa...
View Details Pharmaceutical PeptidesShort-acting GHRH analog that mimics the natural pulsatile release pattern of growth hormone for phy...
View Details Pharmaceutical PeptidesAnti-inflammatory tripeptide derived from alpha-MSH C-terminus with potent effects on inflammatory b...
View Details